DINGDANG HEALTH (09886) spent 273,300 Hong Kong dollars on November 28 to repurchase 251,000 shares.
Dingdang Health (09886) announced that on November 28, 2025, the company will spend 273,300 Hong Kong dollars to repurchase 251,000 shares at a repurchase price of 1.08-1.09 Hong Kong dollars per share.
DINGDANG HEALTH (09886) announced on November 28, 2025 that the company repurchased 251,000 shares at a cost of HK$273,300, with a repurchase price ranging from HK$1.08 to HK$1.09 per share.
Related Articles

China Jushi Co., Ltd (600176.SH) intends to increase its shareholding in the company by 125 million to 250 million yuan.

Suzhou Hycan Holdings (002787.SZ) plans to repurchase 30 to 60 million yuan.

CHENMING PAPER (01812): The 4.1 billion company A shares held by the largest shareholder Chenming Holdings were judicially frozen.
China Jushi Co., Ltd (600176.SH) intends to increase its shareholding in the company by 125 million to 250 million yuan.

Suzhou Hycan Holdings (002787.SZ) plans to repurchase 30 to 60 million yuan.

CHENMING PAPER (01812): The 4.1 billion company A shares held by the largest shareholder Chenming Holdings were judicially frozen.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


